immunological virological mechanisms vaccine-mediated protection siv hiv
major challenge development highly effective aids vaccine identification mechanisms protective immunity address question used nonhuman primate challenge model simian immunodeficiency virus siv show antibodies siv envelope necessary sufficient prevent infection moreover sequencing viruses breakthrough infections revealed selective pressure neutralization-sensitive viruses identified two-amino-acid signature alters antigenicity confers neutralization resistance similar signature confers resistance human immunodeficiency virus hiv neutralization monoclonal antibodies variable regions v1v2 suggesting siv hiv share fundamental mechanism immune escape vaccine-elicited naturally elicited antibodies analyses provide insight limited efficacy seen hiv vaccine trials
